ask="4.73"
ask_size="2700"
average_daily_volume="67253"
bid="2.80"
bid_size="100"
book_value="1.19"
change="-0.01"
change_from_200_day_moving_average="-0.97"
change_from_50_day_moving_average="-0.06"
change_from_52_week_high="-3.55"
change_From_52_week_low="0.41"
change_in_percent="-0.34%"
close="2.92"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.90"
ebitda="-15.74M"
eps_estimate_current_year="-3.71"
eps_estimate_next_quarter="-0.83"
eps_estimate_next_year="-3.33"
ex_dividend_date="N/A"
float_shares="5308000"
high="3.00"
high_52_weeks="6.47"
last_trade_date="3/2/2017"
last_trade_price="2.92"
last_trade_size="158"
last_trade_time="4:00pm"
low="2.84"
low_52_weeks="2.51"
market_capitalization="18.38M"
moving_average_200_day="3.89"
moving_average_50_day="2.98"
name="MABVAX THERAPEUTICS"
notes="N/A"
one_year_target_price="18.00"
open="2.97"
pe_ratio="N/A"
peg_ratio="-0.01"
percent_change_from_200_day_moving_average="-24.90%"
percent_change_from_50_day_moving_average="-2.14%"
percent_change_from_52_week_high="-54.90%"
percent_change_from_52_week_low="+16.16%"
previous_close="2.93"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.46"
price_per_sales="20.37"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="7.82"
stock_exchange="NCM"
symbol="MBVX"
volume="42689"
weeks_range_52="2.51 - 6.47"
